Clinical Trial Update: A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of docetaxel and oxaliplatin in patients with recurrent or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Korean Breast Cancer Study Group | Conditions: Recurrent Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN